Suppr超能文献

[游离/总前列腺特异性抗原(PSA)比值在PSA水平处于灰色地带患者前列腺癌检测中的应用]

[Free/total ratio of prostate-specific antigen (PSA) for prostate cancer detection in patients with gray zone PSA level].

作者信息

Tanaka M, Murakami S, Igarashi T, Abe T, Suzuki K, Sekita N, Shimazaki J

机构信息

Department of Urology, Asahi General Hospital.

出版信息

Hinyokika Kiyo. 1997 Dec;43(12):855-60.

PMID:9488932
Abstract

Thirty seven patients complaining of voiding disturbance who showed gray zone total prostate-specific antigen (t-PSA) level (upper limit of normal approximately 10 ng/ml) but did not reveal apparent cancerous findings in the prostate were examined for free PSA (f-PSA) and prostate volume. According to histological diagnosis, 9 were cancer cases and the other 28 were non-cancer cases. The free/total (F/T) ratio was 0.10 and 0.16 in the cancer and non-cancer groups, respectively (t-PSA; DPC kit, p = 0.03). The t-PSA (DPC and Dinabott kits), f-PSA and PSA density alone did not distinguish these two groups. For diagnosis of cancer, the ratio seemed to be F/T, the most reliable followed by PSA density and t-PSA. When using a 13% F/T, the sensitivity and specificity for cancer detection were 88.9 and 70.8%, respectively. t-PSA measured with the Dinabott kit, showed a similar tendency except that the F/T ratio showed a slight variation. Prostate volume and patient age influenced the F/T slightly, but these factors may not impair the usefulness of F/T.

摘要

37例主诉排尿障碍的患者,其总前列腺特异性抗原(t-PSA)水平处于灰色区间(正常上限约为10 ng/ml),且前列腺未发现明显癌变迹象,对其进行了游离PSA(f-PSA)和前列腺体积检测。根据组织学诊断,9例为癌症病例,其余28例为非癌症病例。癌症组和非癌症组的游离/总(F/T)比值分别为0.10和0.16(t-PSA;DPC试剂盒,p = 0.03)。单独的t-PSA(DPC和Dinabott试剂盒)、f-PSA和PSA密度无法区分这两组。对于癌症诊断,F/T比值似乎是最可靠的,其次是PSA密度和t-PSA。当F/T比值为13%时,癌症检测的灵敏度和特异性分别为88.9%和70.8%。用Dinabott试剂盒测量的t-PSA显示出类似趋势,只是F/T比值略有变化。前列腺体积和患者年龄对F/T有轻微影响,但这些因素可能不会损害F/T的实用性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验